Health
Video: An infectious disease expert explains the results from Moderna’s latest vaccine trials – The Conversation US
The results from the phase 1 trial are a promising first step in showing that the mRNA vaccine is a viable candidate, but there are unanswered questions and it is still early in the process.
Biotech company Moderna, one of many organizations developing a vaccine for COVID-19, published results from an early-stage test of its experimental mRNA vaccine in the New England Journal of Medicine July 14. Vanderbilt University Medical Center staff scientist and protein chemistry expert Sanjay Mishra explains what the results of the phase 1 trial mean.
In this video interview, Sanjay Mishra summarizes the results of a phase 1 trial from one COVID-19 vaccine candidate.
What was Moderna test…
Continue Reading